| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 4.519 | 30.619 | 12.521 | 29.806 | 12.136 | 20.611 |
| Total Income - EUR | - | - | 0 | 964 | 16.657 | 46.496 | 20.229 | 60.381 | 11.855 | 27.535 |
| Total Expenses - EUR | - | - | 4.305 | 7.692 | 34.894 | 50.789 | 26.937 | 42.705 | 27.472 | 29.233 |
| Gross Profit/Loss - EUR | - | - | -4.305 | -6.728 | -18.237 | -4.293 | -6.708 | 17.676 | -15.616 | -1.699 |
| Net Profit/Loss - EUR | - | - | -4.305 | -6.728 | -18.282 | -4.600 | -6.913 | 17.056 | -15.738 | -1.908 |
| Employees | - | - | 0 | 1 | 4 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Supplements Labs Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 3.767 | 43.226 | 51.138 | 40.761 | 30.842 | 15.062 | 10.560 | 5.246 |
| Current Assets | - | - | 1.719 | 52.823 | 30.584 | 52.467 | 59.602 | 67.156 | 53.982 | 55.961 |
| Inventories | - | - | 0 | 0 | 13.111 | 29.696 | 34.909 | 41.860 | 41.175 | 40.763 |
| Receivables | - | - | 1.195 | 9.395 | 14.446 | 16.787 | 14.384 | 11.416 | 4.708 | 5.981 |
| Cash | - | - | 524 | 43.428 | 3.026 | 5.983 | 10.308 | 13.880 | 8.100 | 9.217 |
| Shareholders Funds | - | - | -4.261 | -10.911 | -28.982 | -33.032 | -39.212 | -22.257 | -37.927 | -39.623 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 9.748 | 64.008 | 77.063 | 102.664 | 115.599 | 97.746 | 95.761 | 100.830 |
| Income in Advance | - | - | 0 | 42.953 | 33.640 | 23.596 | 14.057 | 6.728 | 6.708 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4634 - 4634" | |||||||||
| CAEN Financial Year |
1089
|
|||||||||
Comments - Supplements Labs Srl